97 related articles for article (PubMed ID: 3877482)
1. Isoelectric focusing of beta-lactamases in Mycobacterium fortuitum. Association of a single enzyme pattern with cefoxitin resistance.
Wallace RJ; Nash DR; Udou T; Steingrube VA; Steele LC; Swenson JM; Silcox VA
Am Rev Respir Dis; 1985 Nov; 132(5):1093-7. PubMed ID: 3877482
[TBL] [Abstract][Full Text] [Related]
2. Characterization of beta-lactamases in Mycobacterium fortuitum including a role in beta-lactam resistance and evidence of partial inducibility.
Nash DR; Wallace RJ; Steingrube VA; Udou T; Steele LC; Forrester GD
Am Rev Respir Dis; 1986 Dec; 134(6):1276-82. PubMed ID: 3491556
[TBL] [Abstract][Full Text] [Related]
3. Isoelectric focusing patterns of beta-lactamases in the rapidly growing mycobacteria.
Zhang Y; Wallace RJ; Steingrube VA; Brown BA; Nash R; Silcox A; Tsukamura M
Tuber Lung Dis; 1992 Dec; 73(6):337-44. PubMed ID: 1292713
[TBL] [Abstract][Full Text] [Related]
4. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum.
Wallace RJ; Brown BA; Silcox VA; Tsukamura M; Nash DR; Steele LC; Steingrube VA; Smith J; Sumter G; Zhang YS
J Infect Dis; 1991 Mar; 163(3):598-603. PubMed ID: 1995732
[TBL] [Abstract][Full Text] [Related]
5. Distribution and characterization of beta-lactamases of mycobacteria and related organisms.
Kwon HH; Tomioka H; Saito H
Tuber Lung Dis; 1995 Apr; 76(2):141-8. PubMed ID: 7780097
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors and inactivators of beta-lactamase from Mycobacterium fortuitum.
Fattorini L; Amicosante G; Fiorentino D; Franceschini N; Di Marzio L; Oratore A; Orefici G
J Chemother; 1989 Oct; 1(5):293-7. PubMed ID: 2585031
[TBL] [Abstract][Full Text] [Related]
7. Beta-lactamase of Mycobacterium fortuitum: kinetics of production and relationship with resistance to beta-lactam antibiotics.
Fattorini L; Scardaci G; Jin SH; Amicosante G; Franceschini N; Oratore A; Orefici G
Antimicrob Agents Chemother; 1991 Sep; 35(9):1760-4. PubMed ID: 1952844
[TBL] [Abstract][Full Text] [Related]
8. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L
Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
[TBL] [Abstract][Full Text] [Related]
9. Characterization of three different beta-lactamases from the Bacteroides fragilis group.
Olsson-Liljequist B; Dornbusch K; Nord CE
Antimicrob Agents Chemother; 1980 Aug; 18(2):220-5. PubMed ID: 6969573
[TBL] [Abstract][Full Text] [Related]
10. Expression and some properties of beta-lactamase from Mycobacterium fortuitum.
Fattorini L; Oliva B; Orefici G
Drugs Exp Clin Res; 1986; 12(12):973-7. PubMed ID: 3494588
[TBL] [Abstract][Full Text] [Related]
11. Cefoxitin sensitivity as a marker for inducible beta-lactamases.
Moritz VA; Carson PB
J Med Microbiol; 1986 May; 21(3):203-7. PubMed ID: 3486293
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.
Cynamon MH; Palmer GS
Antimicrob Agents Chemother; 1983 Jun; 23(6):935-7. PubMed ID: 6604496
[TBL] [Abstract][Full Text] [Related]
13. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
Eley A; Greenwood D
J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Mycobacterium fortuitum to cefoxitin.
Cynamon MH; Patapow A
Antimicrob Agents Chemother; 1981 Jan; 19(1):205-7. PubMed ID: 7247358
[TBL] [Abstract][Full Text] [Related]
15. Group 1 beta-lactamases of Aeromonas caviae and their resistance to beta-lactam antibiotics.
Lupiola-Gómez PA; González-Lama Z; Tejedor-Junco MT; González-Martín M; Martín-Barrasa JL
Can J Microbiol; 2003 Mar; 49(3):207-15. PubMed ID: 12795407
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of resistance determinants to cefamandole and cefoxitin in Enterobacter cloacae strains.
Vuye A
Microbios; 1983; 38(153-154):159-69. PubMed ID: 6606106
[TBL] [Abstract][Full Text] [Related]
18. Isoelectric focusing studies on Mycobacterium chelonei.
Sparks J; Ross GW
Tubercle; 1981 Dec; 62(4):289-93. PubMed ID: 6977905
[TBL] [Abstract][Full Text] [Related]
19. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
Coşkun S; Altanlar N
Mikrobiyol Bul; 2012 Jul; 46(3):375-85. PubMed ID: 22951650
[TBL] [Abstract][Full Text] [Related]
20. Relationships between beta-lactamase production and beta-lactam susceptibility of environmental strains of Yersinia kristensenii.
Ahmedy AM; Vidon DJ; Labia R; Delmas CL
Res Microbiol; 1989; 140(9):667-77. PubMed ID: 2626595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
